Vice President Of Preclinical Development, Kymera Therapeutics
Haojing Rong is the Vice President of Preclinical Development at Kymera Therapeutics. She earned her Ph.D. at Faculty of Pharmaceutical Science of Ghent University in Belgium. Haojing started her career in the DMPK area at Amgen, Thousand Oaks, CA, followed by experiences at several large and small companies such as Merck, Amira Pharmaceuticals, and Pfizer Groton and Cambridge. She was a Director of Nonclinical Development at Shire prior to joining Kymera in 2018. Haojing’s interest and expertise include ADME and Tox knowledge integration for both small molecule and biotherapeutics, prediction of human pharmacokinetics, drug interactions using modeling and simulation, and applying integrated PK/PD modeling approach for both efficacy and safety for drug development.